GLS and neoplasm: demonstrated that in effector T-cell populations with transient GLS deficiency, IL2 promotes Th1 phenotype and CD8 T-cell function, suggesting that inhibition of glutamine metabolism enhances an anti-tumor immune composition (24, 50).